The global autotransfusion devices market, valued at US$ 382.3 Mn in 2022, is projected to grow at a CAGR of 4.7% between 2023 and 2031, reaching US$ 573.0 Mn by 2031, according to a recent market analysis. The increasing demand for efficient blood management solutions, declining availability of allogeneic blood, and rising awareness of autotransfusion benefits are key factors driving this growth.
Examine key highlights and takeaways from our Report in this sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40781
Market Drivers: Surge in Surgical Procedures and Technological Innovations
Autotransfusion, which involves collecting and reinfusing a patient’s own blood during surgery, is becoming a preferred alternative to traditional blood transfusions due to its ability to reduce infection risks and donor dependency. The rising volume of complex surgeries, particularly in cardiac, orthopedic, and trauma cases, is fueling market expansion.
- Rising Chronic Disease Burden: A 2023 study found that over 40% of adults in India suffer from at least one chronic condition, increasing the need for advanced surgical interventions.
- Cardiac Surgery Growth: According to the German Society for Thoracic and Cardiovascular Surgery, over 162,000 heart procedures were recorded in 2022, demonstrating the growing demand for efficient blood conservation techniques.
- Technological Advancements: In March 2023, Haemonetics Corporation received FDA 510(k) clearance for its next-generation software upgrade for the Cell Saver Elite+ Autotransfusion System, improving efficiency and ease of use for medical professionals.
Competitive Landscape: Key Players Expanding Product Offerings
Leading companies in the autotransfusion devices market include:
- Fresenius Kabi AG
- Haemonetics Corporation
- LivaNova PLC
- Medtronic
- Terumo Corporation
- Stryker
- Atrium Medical Technologies
- Advancis Surgical
These firms are focusing on product innovation, strategic mergers, and partnerships to expand their global presence. For instance, ProCell Surgical introduced its ProCell medical device in 2020, automating surgical sponge-blood recovery for intraoperative autotransfusion, further streamlining surgical procedures.
Review significant findings and insights from our Report in this sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40781
Market Segmentation: Growing Adoption in Ambulatory Surgical Centers
By Product Type:
- On-pump Transfusion Devices
- Off-pump Transfusion Devices
By End-user:
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Cardiac Research Centers
Ambulatory surgical centers (ASCs) held a major share in 2022 due to specialized surgical expertise, advanced medical equipment, and lower infection risks compared to hospitals. The increasing adoption of minimally invasive procedures in ASCs is further driving the demand for autotransfusion systems.
Regional Insights: North America Maintains Market Leadership
North America led the autotransfusion devices market in 2022, supported by a strong healthcare infrastructure and a high prevalence of cardiovascular diseases. The U.S. alone reported 695,000 heart disease-related deaths in 2021, underscoring the demand for effective blood management solutions.
Other key regional insights include:
- Europe: Growth driven by a rising number of surgical procedures and the presence of leading medical device manufacturers.
- Asia Pacific: Rapid healthcare investments and an expanding patient base in China and India are propelling market growth.
- South America, Middle East & Africa: Increasing adoption of advanced medical technologies in emerging healthcare systems.
Future Outlook: Innovations and Strategic Market Expansion
With continued technological advancements and the increasing emphasis on patient blood management, the autotransfusion devices market is poised for steady growth. Industry leaders are investing in R&D, product enhancements, and geographic expansion to meet the evolving needs of healthcare providers worldwide.
For more insights into the Autotransfusion Devices Market Report, including detailed segmentation, key company profiles, and emerging trends, request a sample brochure today.
Buy this Premium Research Report and unlock critical data and findings – https://www.transparencymarketresearch.com/checkout.php?rep_id=40781<ype=S
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: [email protected]
Follow Us: LinkedIn| Twitter| Blog | YouTube




